Therefore, targeted inhibition of the CCL20/CCR6 axis eliminates macrophage-mediated pro-proliferation and migration of ESCs, which is an effective strategy to inhibit EMs progression. The gene discussed is CCL20; the disease is eosinophilia-myalgia syndrome.